Treatment Overview
Bone marrow is the substance in the centre of your
bones that produces red blood cells. A person with
sickle cell disease has bone marrow that produces red
blood cells with defective hemoglobin S. But if that bone marrow is replaced
with healthy bone marrow, a person's body may start to produce normal
hemoglobin. Bone marrow transplants require bone
marrow from another person (donor) and carry a high degree of risk. They are
used only in cases of severe sickle cell disease for children who have minimal
organ damage due to the disease. Experts consider the procedure
experimental.
Before the transplant, bone marrow stem cells are taken from a
healthy brother or sister who has closely matching bone marrow. The child who
has sickle cell disease is then treated with drugs that destroy his or her bone
marrow cells. After that, the donated bone marrow stem cells are injected into
a vein.
Once the process is complete, the donor's bone marrow begins to
replace the recipient's bone marrow. These new cells restore the
immune system and make normal red blood cells.
What To Expect After Treatment
After bone marrow transplant, recovery takes 1 to 2 months in the
hospital. The child's natural defence system needs this time to start working
again.
During recovery, health professionals watch closely for signs that
the immune system is rejecting the new bone marrow and for signs of infection.
If a problem occurs, recovery can take longer or the transplant may
fail.
Why It Is Done
Bone marrow transplants offer a potential cure for a child's sickle
cell disease. They are considered only for children younger than 16 who have:
- Severe sickle cell disease complications,
including repeat
strokes, episodes of
acute chest syndrome, and
painful events.
- An available donor (a
healthy brother or sister who has matching bone marrow).
- No
significant damage to major organs.
About 1% of people with sickle cell disease meet the criteria for
bone marrow transplant.1
How Well It Works
If successful, a bone marrow transplant can cure sickle cell
disease. Although only used in select cases, it is successful in nearly 85% of
transplant recipients. Another 10% survive, despite transplant complications or
failure. About 5% percent of bone marrow transplant recipients die following
the procedure.2
Risks
- Any bone marrow transplant is risky because
complications, such as severe infections and immune system problems, can occur.
- If the recipient's natural defence (immune) system isn't weakened enough by the
medications given before the transplant, it can attack the new stem cells and
cause the transplant to fail.
- If the donor's stem cells don't match
the recipient's closely enough, the donor's new immune system cells may attack
certain organs in the recipient (graft versus host disease).
- Other
complications can include seizures and bleeding in the brain.
- In some cases, this disease can cause long-term
sickness or death (5% of bone marrow transplant recipients die).2
- A
person may be unable to have children (infertile) after a bone marrow
transplant.
What To Think About
- Transplanted bone marrow doesn't always work
properly. This can cause life-threatening problems.
- Bone marrow
transplantation is still an experimental treatment, and only about 200 people
with sickle cell disease have had this procedure.3
- Very few hospitals offer this
procedure.
- The risks of bone marrow transplantation become greater
as a person gets older and/or develops damage to major organs. For these
reasons, a bone marrow transplant is not a treatment option for adults with
sickle cell disease.
Complete the
special treatment information form (PDF)
(What is a PDF document?)
to help you understand this treatment.